Katy Trent

988 total citations
4 papers, 543 citations indexed

About

Katy Trent is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Katy Trent has authored 4 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 1 paper in Organic Chemistry and 1 paper in Computational Theory and Mathematics. Recurrent topics in Katy Trent's work include DNA and Nucleic Acid Chemistry (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and RNA Interference and Gene Delivery (1 paper). Katy Trent is often cited by papers focused on DNA and Nucleic Acid Chemistry (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and RNA Interference and Gene Delivery (1 paper). Katy Trent collaborates with scholars based in United States. Katy Trent's co-authors include William G. Rice, Michael K. Schwaebe, Jeffrey P. Whitten, Denis Drygin, Caroline B. Ho, Adam Siddiqui-Jain, Amy Lin, Sean O’Brien, Daniel D. Von Hoff and Kenna Anderes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Katy Trent

4 papers receiving 533 citations

Peers

Katy Trent

MB

ONCOL

OC

PHARM

IMMUN

B. Chie-Leon United States

Charles A. Mayfield United States

Laura C. Cesa United States

Pallabi Sengupta India

Blanka Sengerová United Kingdom

Jana Škerlová Czechia

Michael Garton Canada

Zutao Yu Japan

Anna A. Lobas Russia

Christine O’Day United States

B. Chie-Leon United States

Katy Trent

468 ×0.9

MB

119 ×2.4

ONCOL

35 ×0.9

OC

21 ×1.1

PHARM

26 ×1.5

IMMUN

Citations per year, relative to Katy Trent Katy Trent (= 1×) peers B. Chie-Leon

Countries citing papers authored by Katy Trent

Since Specialization

Citations

This map shows the geographic impact of Katy Trent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Trent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Trent more than expected).

Fields of papers citing papers by Katy Trent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Trent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Trent. The network helps show where Katy Trent may publish in the future.

Co-authorship network of co-authors of Katy Trent

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Trent. A scholar is included among the top collaborators of Katy Trent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Trent. Katy Trent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Drygin, Denis, Adam Siddiqui-Jain, Sean O’Brien, et al.. (2009). Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis. Cancer Research. 69(19). 7653–7661. 462 indexed citations

2.

Drygin, Denis, William G. Rice, Sean O’Brien, et al.. (2008). Quarfloxin (CX-3543) disrupts the Nucleolin/ rDNA quadruplex complexes, inhibits the elongation by RNA Polymerase I and exhibits potent antitumor activity in models of cancer. Cancer Research. 68. 3301–3301. 6 indexed citations

3.

Rice, William G., Michael K. Schwaebe, Adam Siddiqui-Jain, et al.. (2005). Clinical development of CX-3543, a novel multi-targeting antitumor agent. Journal of Clinical Oncology. 23(16_suppl). 3206–3206. 7 indexed citations

4.

Kamal, Adeela, David J. Busch, Lin Zhang, et al.. (2004). Synthesis and Biological Evaluation of a New Class of Geldanamycin Derivatives as Potent Inhibitors of Hsp90. Journal of Medicinal Chemistry. 47(15). 3865–3873. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact